CompletedNCT01891721
Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesSchizophreniaBehavioural studyAges 25–65
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT01422902
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults
Official study title
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults, A Remediation-based Approach
This study has finished and is no longer accepting participants.
Multiple locations, including Palo AltoSchizophreniaInterventional studyAges 18+
CompletedNCT01378403
Evaluation of Dorsal Visual Stream in people with Schizophrenia
Official study title
Evaluation of Dorsal Visual Stream in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Ramat GanSchizophreniaObservational studyAges 18–35
CompletedNCT03338179
Evaluation of Metamemory in people with Schizophrenia
Official study title
Evaluation of Metamemory in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Clermont-FerrandSchizophreniaBehavioural studyAges 18+
CompletedNCT01263080
Evaluation of Mirtazapine and Folic Acid for Schizophrenia:
Official study title
Multicentre Randomised Double-blind, Placebo-controlled 2x2 Factorial Trial Investigating the Effects of Adding Mirtazapine and Folic Acid to Existing Therapy for Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BeijingSchizophreniaMedication studyAges 18–70
TerminatedNCT02614586
Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in people with Stable Schizophrenia
Official study title
A Placebo-Controlled Study to Evaluate the Effect of a Single Dose of TAK-058 and Ondansetron on P50 Auditory Gating in Subjects With Stable Schizophrenia
This study ended early.
In St LouisSchizophreniaMedication studyAges 18–60
CompletedNCT02874560
Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia
This study has finished and is no longer accepting participants.
In ParisSchizophreniaObservational studyAges 18–37
CompletedNCT04087954
Evaluation the Impact of Self-Stigma Reduction Program on Psychosocial Outcomes Among People Diagnosed With Schizophrenia
This study has finished and is no longer accepting participants.
In AmmanSchizophreniaBehavioural studyAges 18+
CompletedNCT04025502
Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects
Official study title
A Multi-Center Study of Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveSchizophreniaObservational studyAges 21–50
CompletedNCT03346291
Examining Persistence in Smokers With Schizophrenia
This study has finished and is no longer accepting participants.
In New BrunswickSchizophreniaBehavioural studyAges 18–64
CompletedNCT04756388
Examining Strategy Monitoring and Remediation Training
Official study title
E-SMART: Examining Strategy Monitoring and Remediation Training for Schizophrenia
This study has finished and is no longer accepting participants.
In TorontoSchizophreniaInterventional studyAges 18–65
CompletedNCT01409590
Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications
This study has finished and is no longer accepting participants.
In Tel HaShomerSchizophreniaBehavioural studyAges 18–35
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.